Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoschisin 1 (RS1) is a secreted extracellular protein primarily expressed in the retina by photoreceptors and bipolar cells. It functions as an adhesion molecule crucial for maintaining the structural integrity and cytoarchitecture of the retina. RS1 forms a homo-oligomeric complex that mediates cell-cell interactions and influences ion channel activity. Mutations in RS1 cause X-linked juvenile retinoschisis (XLRS), a hereditary eye disease characterized by retinal splitting and progressive vision loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoschisin 1 (RS1).